82 related articles for article (PubMed ID: 20718658)
21. [Value of antibody coated bacteria in the localization and follow-up of chronic urinary tract infections (author's transl)].
André J; Arnaud B; Pilonchery G; Leriche A
Ann Biol Clin (Paris); 1980; 38(2):111-4. PubMed ID: 6992658
[TBL] [Abstract][Full Text] [Related]
22. Haemophilus influenzae type b (HIB)-conjugate immunization before bone marrow harvest in autologous bone marrow transplantation.
Molrine DC; Guinan EC; Antin JH; Wheeler C; Parsons SK; Weinstein HJ; McGarigle C; Blanding P; Phillips NR; Ciamarra A; George S; Ambrosino DM
Bone Marrow Transplant; 1996 Jun; 17(6):1149-55. PubMed ID: 8807128
[TBL] [Abstract][Full Text] [Related]
23. Mucosal immunization with purified flagellin from Salmonella induces systemic and mucosal immune responses in C3H/HeJ mice.
Strindelius L; Filler M; Sjöholm I
Vaccine; 2004 Sep; 22(27-28):3797-808. PubMed ID: 15315861
[TBL] [Abstract][Full Text] [Related]
24. IgM antibodies to native phenolic glycolipid-I in contacts of leprosy patients in Venezuela: epidemiological observations and a prospective study of the risk of leprosy.
Ulrich M; Smith PG; Sampson C; Zuniga M; Centeno M; Garcia V; Manrique X; Salgado A; Convit J
Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):405-15. PubMed ID: 1890364
[TBL] [Abstract][Full Text] [Related]
25. Vaginal mucosal immunization for recurrent urinary tract infection: phase II clinical trial.
Uehling DT; Hopkins WJ; Balish E; Xing Y; Heisey DM
J Urol; 1997 Jun; 157(6):2049-52. PubMed ID: 9146577
[TBL] [Abstract][Full Text] [Related]
26. The biological effects of IgM hexamer formation.
Randall TD; King LB; Corley RB
Eur J Immunol; 1990 Sep; 20(9):1971-9. PubMed ID: 2120070
[TBL] [Abstract][Full Text] [Related]
27. Vaccination approaches for the prevention of urinary tract infection.
Moriel DG; Schembri MA
Curr Pharm Biotechnol; 2013; 14(11):967-74. PubMed ID: 24372245
[TBL] [Abstract][Full Text] [Related]
28. [The frequency of detection of IgA, IgG and IgM antibodies to pertussis toxin in patients with respiratory tract infections in Poland].
Rastawicki W; Rokosz N; Jagielski M
Przegl Epidemiol; 2009; 63(4):513-8. PubMed ID: 20120949
[TBL] [Abstract][Full Text] [Related]
29. Immunization of humans with polysaccharide vaccines induces systemic, predominantly polymeric IgA2-subclass antibody responses.
Tarkowski A; Lue C; Moldoveanu Z; Kiyono H; McGhee JR; Mestecky J
J Immunol; 1990 May; 144(10):3770-8. PubMed ID: 2110213
[TBL] [Abstract][Full Text] [Related]
30. Phase 2 clinical trial of a vaginal mucosal vaccine for urinary tract infections.
Uehling DT; Hopkins WJ; Elkahwaji JE; Schmidt DM; Leverson GE
J Urol; 2003 Sep; 170(3):867-9. PubMed ID: 12913718
[TBL] [Abstract][Full Text] [Related]
31. Increased serum IgM class anti-lipid A antibody and therapeutic effect of ursodeoxycholic acid in primary biliary cirrhosis.
Ide T; Sata M; Nakano H; Suzuki H; Tanikawa K
Hepatogastroenterology; 1997; 44(18):1569-73. PubMed ID: 9427024
[TBL] [Abstract][Full Text] [Related]
32. The effects of vaccination with inactivated uropathogenic bacteria in recurrent urinary tract infections of children.
Nayir A; Emre S; Sirin A; Bulut A; Alpay H; Tanman F
Vaccine; 1995 Aug; 13(11):987-90. PubMed ID: 8525693
[TBL] [Abstract][Full Text] [Related]
33. [Immunomodulation of recurrent urinary tract infections with Urvakol vaccine].
Koukalová D; Reif R; Hájek V; Mucha Z; Veselý J; Viktorinová M; Lochman I
Bratisl Lek Listy; 1999 May; 100(5):246-51. PubMed ID: 10500328
[TBL] [Abstract][Full Text] [Related]
34. IgM hexamers?
Brewer JW; Randall TD; Parkhouse RM; Corley RB
Immunol Today; 1994 Apr; 15(4):165-8. PubMed ID: 8198707
[TBL] [Abstract][Full Text] [Related]
35. Overview on the clinical studies with Urostim immunostimulator against urogenital infections.
Nenkov P
Adv Exp Med Biol; 2000; 485():325-9. PubMed ID: 11109124
[No Abstract] [Full Text] [Related]
36. Phase I clinical trial of vaginal mucosal immunization for recurrent urinary tract infection.
Uehling DT; Hopkins WJ; Dahmer LA; Balish E
J Urol; 1994 Dec; 152(6 Pt 2):2308-11. PubMed ID: 7966729
[TBL] [Abstract][Full Text] [Related]
37. Elevation of secretory IgA antibodies in the urinary tract by immunostimulation for the pre-operative treatment and post-operative prevention of urinary tract infections.
Rüttgers H; Grischke E
Urol Int; 1987; 42(6):424-6. PubMed ID: 3448808
[TBL] [Abstract][Full Text] [Related]
38. Reactivity of IgM antibodies elicited by PEGylated liposomes or PEGylated lipoplexes against auto and foreign antigens.
Ando H; Abu Lila AS; Kawanishi M; Shimizu T; Okuhira K; Ishima Y; Ishida T
J Control Release; 2018 Jan; 270():114-119. PubMed ID: 29217175
[TBL] [Abstract][Full Text] [Related]
39. Association of human leucocyte antigen phenotype with vaccine efficacy in patients receiving vaginal mucosal immunization for recurrent urinary tract infection.
Hopkins WJ; Heisey DM; Uehling DT
Vaccine; 1999 Jan; 17(2):169-71. PubMed ID: 9987151
[TBL] [Abstract][Full Text] [Related]
40. [Use of vaccines for prophylaxis of urinary tract infections].
Carraro-Eduardo JC; Gava IA
J Bras Nefrol; 2012 Jun; 34(2):178-83. PubMed ID: 22850920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
